Hutch News
Results per Page:
Send in the CARs: mesothelin-targeted CAR T cells against AML
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues
Taking aim: Mesothelin as a novel target for pediatric AML therapy
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues
Keep your enemies closer: targeting membrane-proximal domains for improved immunotherapy
From the Walter Lab, Clinical Research Division
Fred Hutch at ASH: Fauci fireside chat, latest on cell therapies, repairing immune function, COVID and clots — and more
The 62nd American Society of Hematology Annual Meeting and Exposition to be held virtually Dec. 5-8, 2020
London transplant doctors report a second person likely cured of HIV
12 years after Timothy Ray Brown was cured, we have another
Lyani Valle: leukemia survivor, Obliteride walker
'Cancer was a huge wake-up call to what is important in life'
MERGE improves precision medicine for acute myeloid leukemia
from Dr. Pamela Becker, Clinical Research Division